Staining kit and method for assessing likelihood of rheumatoid arthritis disease risk

TW202642160APending Publication Date: 2026-10-16FULLHOPE BIOMEDICAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115110054
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-03-31
Filing Date
2026-03-17
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001081230_001
    Figure TWG2TA001081230_001
  • Figure TWG2TA001081230_002
    Figure TWG2TA001081230_002
  • Figure TWG2TA001081230_003
    Figure TWG2TA001081230_003
Patent Text Reader

Abstract

A staining kit is provided, including a first pattern including antibodies against CD3, CD4, CD8, CD14, CD19, CD25, CD45, CD56, CTLA4, FoxP3 and PD-1; a second pattern including antibodies against CD3, CD4, CD14, CD19, CD45, CD56, HLA-DR, PD-1 and PD-L1; a third pattern including antibodies against CD3, CD11b, CD14, CD16, CD19, CD45, CD56, CD66b, CD123 and CD193; and a fourth pattern including antibodies against CD10, CD19, CD21, CD23, CD38, CD45, CD127, IgG and IgM, wherein the antibodies of each pattern are labeled with fluorescent dyes. A method of assessing the likelihood of a rheumatoid arthritis (RA) disease risk in a subject using the staining kit is also provided.
Need to check novelty before this filing date? Find Prior Art